Ensitrelvir

Chemical compound

Ensitrelvir, sold under the brand name Xocova, is an antiviral medication used as a treatment for COVID-19 and as post-exposure prophylaxis (PEP) to prevent COVID-19 infections following exposure. It was developed by Shionogi in partnership with Hokkaido University and acts as an orally active 3C-like protease inhibitor.

Nº Q110798570 ★★

Peu commune · Savoirs

Ensitrelvir

Chemical compound

Texte en anglais

Ensitrelvir, sold under the brand name Xocova, is an antiviral medication used as a treatment for COVID-19 and as post-exposure prophylaxis (PEP) to prevent COVID-19 infections following exposure. It was developed by Shionogi in partnership with Hokkaido University and acts as an orally active 3C-like protease inhibitor.

Dernier prix

—

Prix plancher

—

Médiane 7 j

—

Ventes 30 j

0

Fourchette 30 j

—

En circulation

0

Cours

Voir le tableau
Datemédiane MinMaxventes

Historique des ventes

Dernière vente
—
Moyenne 30 j
—
Plus bas 30 j
—
Plus haut 30 j
—
Ventes 7 j
0
Ventes 30 j
0

Aucune vente pour l'instant.

Ventes anonymes : ni acheteur ni vendeur. Les chiffres ne comptent que les ventes entre joueurs.

Sur Wikipédia

Texte en anglais Pas encore d'article dans ta langue : extrait en anglais.

Ensitrelvir, sold under the brand name Xocova, is an antiviral medication used as a treatment for COVID-19 and as post-exposure prophylaxis (PEP) to prevent COVID-19 infections following exposure. It was developed by Shionogi in partnership with Hokkaido University and acts as an orally active 3C-like protease inhibitor. It is taken by mouth. The most common adverse events include transient decreases in high-density lipoprotein and increased blood triglycerides.

Texte : Wikipédia en anglais, CC BY-SA 4.0. · Image : User:Innerstream (Public domain) ·

Cartes voisines

Voir la fiche

Confirmation